Blue Water Life Science Advisors, LP 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Blue Water Life Science Advisors, LP disclosed 7 US equity positions worth $109.6m in its Q3 2025 13F filing. The largest position was ADPT at 29.3% of the reported book, followed by GH and NTRA. Against the Q2 2025 filing, it opened 1 new position, added to 0 and reduced 3 among the top 7 holdings.
What did Blue Water Life Science Advisors, LP own in Q3 2025? Top 7 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ADPT ADAPTIVE BIOTECHNOLOGIES | Healthcare | 29.3% | $32.1m | 2,145,145 | 0% | held |
| 2 | GH GUARDANT HEALTH INC | Healthcare | 23.1% | $25.3m | 405,647 | -8% | reduced |
| 3 | NTRA NATERA INC | Healthcare | 20.8% | $22.8m | 141,494 | -15% | reduced |
| 4 | PSNL PERSONALIS INC | Healthcare | 10.0% | $10.9m | 1,676,300 | 0% | held |
| 5 | CDNA CAREDX INC | Healthcare | 6.8% | $7.4m | 510,000 | -30% | reduced |
| 6 | TEM TEMPUS AI INC | Healthcare | 5.3% | $5.8m | 72,412 | – | new |
| 7 | QTRX QUANTERIX CORP | Healthcare | 4.7% | $5.2m | 957,747 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.